Summary
Activity of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT) is an important determinant of responsiveness of tumor cells to chloroethylnitrosoureas (CENUs), representative chemotherapeutic agents for primary malignant gliomas. In order to assess the real states of this repair protein in human malignant gliomas, we assayed AGT activity in surgically extirpated 42 malignant glioma samples and studied the distribution of the activity under certain clinical conditions. There were wide variations in AGT activity between individuals. No significant difference in AGT activity on average was seen either between glioblastoma and anaplastic astrocytoma, nor between primary and recurrent tumors. Among 42 malignant gliomas, 7 samples (16.7%) had low AGT activity less than 0.1 pmoles/mg protein. In the case of glioblastoma, tumors possessing higher AGT activity tended to be less responsive to post-operation remission-induction therapy including CENUs. The result of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) chemosensitivity assay by using the corresponding surgical specimens suggested a close relationship between cellular resistance to CENUs and AGT activity. It was found to be unlikely that a short term administration of CENUs had a significant effect on AGT activity of brain tumors in human body. We could detect a bit of definite evidences of the relevance of AGT to resistance to CENUs and need to conduct further investigations for other resistance factors.
Similar content being viewed by others
References
Levin VA, Wilson CB: Nitrosourea chemotherapy for primary malignant gliomas. Cancer Treat Rep 60: 719–724, 1976
Bodell WJ, Gerosa M, Aida T, Berger MS, Rosenblum ML: Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res 45: 3460–3464, 1985
Satoh MS, Huh N, Horie Y, Thomale J, Rajewsky MF, Kuroki T: Acquisition of resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in V79 cells through increased removal of O6-alkylguanine. Jpn J Cancer Res 78: 1094–1099, 1987
Bodell WJ, Tokuda K, Ludlum DB: Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea. Cancer Res 48: 4489–4492, 1988
Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M: Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains. Acta Neurochir (Wien) 103: 62–66, 1990
Smith DG, Brent TP: Response of cultured human cell lines from rhabdomyosarcoma xenografts to treatment with chloroethylnitrosoureas. Cancer Res 49: 883–886, 1989
Hotta T, Saito Y, Mikami T, Kurisu K, Kiya K, Uozumi T, Isowa G, Ishizaki K, Ikenaga M: Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines. J Neuro-Oncol 17: 1–8, 1993
Isowa G, Ishizaki K, Sadamoto T, Tanaka K, Yamaoka Y, Ozawa K, Ikenaga M: O6-methylguanine-DNA methyltransferase activity in human liver tumors. Carcinogenesis 12: 1313–1317, 1991
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983
Citron M, Graver M, Schoenhaus M, Chen S, Decker R, Kleynerman L, Kahn LB, White A, Fornace AJ, Yarosh D: Detection of messenger RNA from O6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues. J Natl Cancer Inst 84: 337–340, 1992
Fornace AJ, Papathanasiou MA, Hollander MC, Yarosh DB: Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER− human tumor cells. Cancer Res 50: 7908–7911, 1990
He X, Ostrowski LE, von Wronski MA, Friedman HS, Wikstrand CJ, Bigner SH, Rasheed A, Batra SK, Mitra S, Brent TP, Bigner DD: Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines. Cancer Res 52: 1144–1148, 1992
Ostrowski LE, von Wronski MA, Bigner SH, Rasheed A, Schold SC, Brent TP, Mitra S, Bigner DD: Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell lines. Carcinogenesis 12: 1739–1744, 1991
Frosina G, Rossi O, Arena G, Gentile SL, Bruzzone E, Abbondandolo A: O6-Alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett 55: 153–158, 1990
Mineura K, Izumi I, Watanabe K, Kowada M: Influence of O6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain tumors. Int J Cancer 55: 76–81, 1993
Wiestier O, Kleihues P, Pegg AE: O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 5: 121–124, 1984
Silber JR, Mueller BA, Ewers TG, Berger MS: Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53: 3416–3420, 1993
Fujio C, Chang HR, Tsujimura T, Ishizaki K, Kitamura H, Ikenaga M: Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the antitumor agent 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea. Carcinogenesis 10: 351–356, 1989
Sagher D, Karrison T, Schwartz JL, Larson R, Meier P, Strauss B: Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia. Cancer Res 48: 3084–3089, 1988
Dolan ME, Larkin GL, English HF, Pegg AE: Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine. Cancer Chemother Pharmacol 25: 103–108, 1989
Dolan ME, Mitchell RB, Mummert C, Moschel RC, Pegg AE: Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 51: 3367–3372, 1991
Gerson SL: Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocinin vivo. Cancer Res 49: 3134–3138, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hotta, T., Saito, Y., Fujita, H. et al. O6-Alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications. J Neuro-Oncol 21, 135–140 (1994). https://doi.org/10.1007/BF01052897
Issue Date:
DOI: https://doi.org/10.1007/BF01052897